Credit rating of Eris Therapeutics Limited
Awaiting price reaction for this filing.
Eris Lifesciences Limited has informed the stock exchanges about a credit rating update for its wholly owned subsidiary, Eris Therapeutics Limited. The rating action was carried out by India Ratings & Research. The filing does not specify the direction of the rating change (whether it was an upgrade, downgrade, or placed on watch). Eris Therapeutics is a wholly owned subsidiary of Eris Lifesciences, so the rating of the subsidiary is being disclosed. The actual rating details would be in the referenced India Ratings press release.
Since the direction of the rating change is not disclosed in this filing, investors should refer to the India Ratings press release for the actual rating action. Any change in the subsidiary's credit rating may have implications for its borrowing costs and financial standing within the Eris group.